Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (71)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Oldfors, A.
Right arrow Articles by Holme, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oldfors, A.
Right arrow Articles by Holme, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 116, No. 2, 325-336, 1993
© 1993 Oxford University Press


research-article

Mitochondrial DNA deletions in inclusion body myositis

Anders Oldfors1, Nils-Göran Larsson2, Christopher Lindberg3 and Elisabeth Holme2

1Pathology Gothenburg, Sweden 2Clinical Chemistry Gothenburg, Sweden 3Neurology, Gothenburg University Gothenburg, Sweden

Correspondence to: Correspondence to: Dr Anders Oldfors, Department of Pathology, Sahlgren's Hospital, S-413 45 Göteborg, Sweden.

Skeletal muscle specimens from three patients with inclusion body myositis, aged 39, 60 and 71 years, respectively, were investigated. Enzyme histochemical staining of cytochrome c oxidase (COX), succinate dehydrogenase and myofibrillar ATPase, and in situ hybridization of transcripts of mitochondrial DNA (mtDNA) were performed on consecutive sections. In all three cases a proportion of muscle fibres (2–5%) showed low or absent COX activity in spite of medium or high succinate dehydrogenase activity (COX deficient muscle fibres). Two probes detecting transcripts of different segments of mtDNA were used for the in situ hybridization. One of the probes (ND4 probe) detected transcripts of a segment of the NADH dehydrogenase subunit 4 gene, which is known to be affected in most cases of mitochondrial myopathy with large deletions of mtDNA. There was reduced hybridization of the ND4 probe in many COX deficient muscle fibres compared with adjacent normal fibres. The other probe (ND2 probe) detected transcripts of a segment of the NADH dehydrogenase subunit 2 gene, which usually is not included in mtDNA deletions. There was accumulation of transcripts corresponding to the ND2 probe in COX deficient fibres in all three cases. These findings demonstrate that deleted mtDNA had accumulated in COX deficient muscle fibres in patients with inclusion body myositis. Southern blot analysis of mtDNA in muscle revealed a 16.6 kb fragment corresponding to normal mtDNA in all three cases. In one case two additional less abundant fragments of smaller size, corresponding to deleted mtDNA, were detected. Ultrastructural investigation showed abnormal mitochondria in all three cases. Control muscle specimens were obtained from nine patients, aged 63 – 71 years, with muscle pain but without morphological evidence of muscle disease. Occasional COX deficient fibres (< 1%) were found in three of the control cases. The other six control cases showed no COX deficient fibres.

Our results show that mtDNA deletions may be involved in the pathogenesis of inclusion body myositis and cause respiratory chain dysfunction in muscle fibre segments.

Received July 23, 1992. Revised October 15, 1992. Accepted October 26, 1992.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
N. Chahin and A. G. Engel
Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM
Neurology, February 5, 2008; 70(6): 418 - 424.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Oldfors, A. R. Moslemi, L. Jonasson, M. Ohlsson, G. Kollberg, and C. Lindberg
Mitochondrial abnormalities in inclusion-body myositis
Neurology, January 24, 2006; 66(1_suppl_1): S49 - S55.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Sorensen, M. Ekstrand, J. P. Silva, E. Lindqvist, B. Xu, P. Rustin, L. Olson, and N.-G. Larsson
Late-Onset Corticohippocampal Neurodepletion Attributable to Catastrophic Failure of Oxidative Phosphorylation in MILON Mice
J. Neurosci., October 15, 2001; 21(20): 8082 - 8090.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Wyss and R. Kaddurah-Daouk
Creatine and Creatinine Metabolism
Physiol Rev, July 1, 2000; 80(3): 1107 - 1213.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. Uusimaa, A. M. Remes, H. Rantala, L. Vainionpää, R. Herva, K. Vuopala, M. Nuutinen, K. Majamaa, and I. E. Hassinen
Childhood Encephalopathies and Myopathies: A Prospective Study in a Defined Population to Assess the Frequency of Mitochondrial Disorders
Pediatrics, March 1, 2000; 105(3): 598 - 603.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.